
Whose skin is the evidence about?
Every product claim rests on studies, and every study rests on the people who took part. In cosmetic science, those people have mostly had lighter skin and lived in milder climates.
The numbers are blunt. A review of five cosmetic-dermatology journals from 2018 to 2023 screened 5,175 articles and found that 561 of them, 10.84%, studied populations that were mostly non-Caucasian. Only 214, 4.14%, reported participants' Fitzpatrick skin type at all (Ehsan et al., 2025). Medical education shows the same pattern: in four widely used anatomy and physical-examination textbooks, 4.5% of images showed dark skin (Louie and Wilkes, 2018).
If the evidence is about someone else's skin, the products built on it are too.
The problems that were never the default
Melanin-rich skin is not simply lighter skin with more pigment. It responds differently to injury and inflammation. Post-inflammatory hyperpigmentation, the dark mark left after a spot, a cut or an over-strong treatment, affects darker-skinned people with greater frequency and severity, and pigment problems are among the most common reasons people with darker skin see a dermatologist (Davis and Callender, 2010). Melasma mainly affects women with more pigmented skin types (Handel et al., 2014). In a study of 1,204 women in four Indian cities, melasma affected about 30% of middle-aged women (Hourblin et al., 2014).
Then there is the weather. Heat waves over central and northwest India are becoming more frequent and longer (Rohini et al., 2016). Sweat, humidity and heat change how products feel, last and smell. Yet most products are developed and tested in mild indoor conditions.
This is not a niche. Melanin-rich skin in hot, humid weather is the everyday reality for a large share of the world.
What changes when you start here
Starting with the skin and climate that were left out changes the questions. A brightening product has to be judged first on whether it irritates, because irritation itself can darken melanin-rich skin. A fragrance has to be judged on warm, sweating skin, not only on a blotter. A body lotion has to feel right at 35 °C and 80% humidity. An odour product has to be judged on what it does to the skin's bacteria, not only on how much it masks.
These are better questions for everyone. A product that is gentle enough for skin that marks easily, and that holds up in heat, will rarely fail on easier skin in milder weather. The reverse often happens.
Six commitments
Anadoris Biotech is at the exploration stage. We have no programmes or results to announce. What we can do now is decide how we will work, and say it publicly so that we can be held to it.
- India-first questions. We start from skin types common in India and from heat and humidity, and treat milder conditions as the edge case.
- Say who was tested. Every study we publish or cite in a claim will state the panel size, skin types and the climate it was run in.
- Methods before results. We will decide how something is measured and what counts as success before testing it, and we will publish results that disappoint us too.
- Claims no bigger than the data. A claim says what was measured, on whom and against what, and nothing more. An ingredient study is not a product claim.
- Honest sourcing. We will ask where every candidate ingredient comes from and what it costs the land and the people who harvest it, before asking how well it performs.
- Work in the open. We will publish our questions, our evidence standard and our methods, and invite researchers, testing labs and brands to challenge them.
What we are asking of the industry
None of this needs new technology. It needs different defaults. Recruit study panels that look like the people who will use the product. Report skin type and climate as routinely as sample size. Test in the conditions a product will be used in. Stop treating melanin-rich skin and hot climates as special cases.
We would rather be one of many companies doing this than the only one. If you are a researcher, a testing lab, an ingredient developer or a brand who wants to build this evidence, we would like to hear from you.
Questions
What does Anadoris Biotech mean by India-first research?
Starting research questions from skin types common in India, from melanin-rich skin and from hot, humid conditions, rather than adapting products designed and tested for lighter skin in mild climates.
How under-represented is darker skin in cosmetic research?
One review of five cosmetic-dermatology journals (2018–2023) found that 10.84% of 5,175 articles studied mostly non-Caucasian populations, and only 4.14% reported participants' Fitzpatrick skin type.
Does Anadoris Biotech have results or products from this research yet?
No. The research is at the exploration stage. The commitments describe how we will work; results will be published only when there is data.
Sources
- Ehsan et al. (2025). Archives of Dermatological Research 317:458 (skin-of-colour representation in cosmetic dermatology journals, 2018–2023)
- Louie & Wilkes (2018). Representations of race and skin tone in medical textbook imagery. Social Science & Medicine 202:38–42
- Davis & Callender (2010). Postinflammatory hyperpigmentation. Journal of Clinical and Aesthetic Dermatology 3(7):20–31
- Handel, Miot & Miot (2014). Melasma: a clinical and epidemiological review. Anais Brasileiros de Dermatologia 89:771–782
- Hourblin et al. (2014). Indian Journal of Dermatology, Venereology and Leprology 80:395–401 (facial pigmentary disorders in 1,204 Indian women)
- Rohini, Rajeevan & Srivastava (2016). On the variability and increasing trends of heat waves over India. Scientific Reports 6:26153
Related
A perspective is an argument, not a study. Figures are from the sources listed, which are not Anadoris studies. Anadoris Biotech’s research is at the exploration stage: no Anadoris results or product claims are made here.